SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-19-138079
Filing Date
2019-05-06
Accepted
2019-05-06 14:18:07
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-1/A d643194ds1a.htm S-1/A 2111863
2 EX-23.1 d643194dex231.htm EX-23.1 1483
3 GRAPHIC g643194g12v33.jpg GRAPHIC 43999
4 GRAPHIC g643194g21t68.jpg GRAPHIC 74799
5 GRAPHIC g643194g66a45.jpg GRAPHIC 55110
6 GRAPHIC g643194g73r13.jpg GRAPHIC 149222
7 GRAPHIC g643194g94z23.jpg GRAPHIC 97252
  Complete submission text file 0001193125-19-138079.txt   2693547
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-230745 | Film No.: 19798927
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1